Introduction
Over half of the world's population is at risk from malaria, involving some 100 countries, 500 million acute infections, and over 1 million deaths recorded per year (1, 2) . As a whole, this situation has shown little improvement in the last 15 years. Vaccine development is proving lengthy and complex, and drug development continues to be a major goal in that the toxicity-related side effects of present chemotherapy render it only partially satisfactory and drug resistance is rife.
In the hope of developing unique strategies for the treatment of malaria, some investigations have concentrated on attempts to identify the natural molecules responsible for "crisis" formation (deranged development and degeneration of in-Data from parts of this paper were presented at the Fourth International Congress on Malaria and Babesiosis, August 1991, in Rio de Janeiro, Brazil, August 1991.
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1. Abbreviations used in this paper: BHT, butylated hydroxytoluene; C18:i,n.9, oleic acid; C182,n6, linoleic acid; C20.4,,-, arachidonic acid; C2a05,n3, eicosapentaenoic acid; C22:0, docosanoic acid; C22:6,n-3 docosahexaenoic acid; DPPC, DL-a-dipalmitoyl phosphatidylcholine; RBC and PRBC, red blood cells and parasitized RBC, respectively; TNFa, tumor necrosis factor a. traerythrocytic malarial parasites; references 3-10). However, crisis-inducing factors still remain ill defined (1 1) . This paper describes the in vitro killing of intraerythrocytic forms ofPlasmodiumfalciparum and the in vivo killing ofP. berghei in mice by polyunsaturated fatty acids. The finding has the potential to be exploited for therapeutic purposes and may help explain mechanisms of crisis formation in vivo. Some ofthese polyunsaturated fatty acids are released by phagocytic leucocytes and/ or may be acquired through normal diet or dietary supplements.
Methods
Parasite. Six isolates of P. falciparum were maintained under in vitro conditions in group O+ human red blood cells (RBC)' in RPMI 1640 medium (Cytosystems Pty. Ltd., Sydney, Australia) supplemented with 10% heat-inactivated group AB' serum, as described previously (12, 13) . Experiments were performed with synchronized and nonsynchronized cultures at 108 RBC/ml with 3-5% parasitemia.
Mice. Female 6-8-wk-old BALB/c mice were used. They were fed with industrial mouse pellets (Milling Industries, Adelaide, South Australia) and water ad lib. Fatty acids. Docosahexaenoic acid (C22:6,,.3), docosahexaenoic acid methyl ester (C22:6n-3 methyl ester), eicosapentaenoic acid (C21 .,3), arachidonic acid (C204n), linoleic acid (C18:2 n-), oleic acid (C,8: n19), docosanoic acid (C22:0), and DL-a-dipalmitoyl phosphatidylcholine (DPPC) were obtained from Sigma Chemical Co. (St. Louis, MO). Lipids were dissolved in redistilled chloroform (10-50 mg/5 ml) and stored under N2 at -20°C. Thin-layer chromatography indicated that the lipids were of high purity. Mixed fatty acid-DPPC micelles were prepared as follows. Fatty acid (8, 32, or 80 gg) and DPPC (fourfold the amount of fatty acid) were dispensed into 10-ml glass tubes and the solvent was evaporated under N2. 2 ml of RPMI 1640 medium was added and the mixture was sonicated for 2 min with an ultrasonic processor (model W-225; Heat Systems-Ultrasonics, Inc., Farmingdale, NY) with 40% duty cycle and output setting 4. The lipid sonicates were clear under these conditions. 50-,ul aliquots ofeach sonicate (containing 4, 16, or 40 jig/ml fatty acid) were used for assays unless stated otherwise.
Growth inhibition assay. This was carried out as described previously (12, 13) with the following modifications. Experiments were conducted in 96-well flat-bottomed microdilution plates (Linbro, Flow Laboratories, Inc., McLean, VA), comparing three different treatment groups. 50 ,ll P. falciparum-infected RBC were mixed with 50 ;il of either fatty acids (40 jig/ml), diluent (DPPC), or malaria medium. The plates were incubated for 2 h at 37'C in 5% CO2 in air. Then the wells were pulsed with 1 jiCi of [3H]hypoxanthine (Amersham Corp., Arlington Heights, IL) in 50 ,l of RPMI 1640 medium and incubated for a further 18 h at 37'C in 5% CO2 in air. Individual well contents were then collected using a semiautomated sample harvester (Titertek, Flow Laboratories, Sydney, Australia) and the [3H]hypoxanthine incorporation was measured in a liquid scintillation counter (model LS 3801; Beckman Instruments, Carlsbad, CA). Percent growth inhibition ofthe parasite was calculated by the following formula: percent inhibition = [(dpm of parasite in diluent) -(dpm of parasite incubated with fatty acids) X 100]/(dpm ofparasite in diluent), where dpm is disintegrations per minute.
Effects ofdifferent concentrations offatty acids on normal and infected RBC. RBC collected from healthy volunteers were suspended in malaria medium in two culture flasks, and the parasite was inoculated into one. After 3 d of culture, both the normal RBC and parasitized RBC (PRBC) were exposed to various concentrations of fatty acids (4, 16 , and 40 ,g/ml at 50 ,A1/5 X l10 RBC). The supernatants were collected from the wells containing normal or PRBC and the hemoglobin release was determined as described previously (14) . Parasite growth inhibition was studied by radiometric assay. Morphology of RBC and PRBC was studied in thin smears.
Effects offish oil on growth ofP. fakiparum. The effects of fish oil (Maxepa, Duncan, Flockhart, UK), containing the triglycerides of 18% wt/wt C2*5,,3 and 12% wt/wt of C22:6,n.3, on P. fakiparum were examined using the growth inhibition assay described above. 50 M1 offish oil at concentrations of 4, 16, 20, and 40 Mg/mi incorporated into DPPC was added to 50 IAl of RBC with 3-5% parasitemia.
Effects of oxidizedfatty acids on growth ofP. fakiparum. C22:6,n 3 and C&.n 6fatty acids were dispensed into 10-ml glass tubes and the solvent was evaporated under N2. The dried residues were autooxidized by exposure to the air at room temperature for 2-4 d. Thin-layer chromatography indicated that > 95% of the parent fatty acids had been oxidized by this procedure. Products included monohydroperoxy derivatives and other more polar oxygenated compounds (15) . These oxidized fatty acids were compared with freshly prepared fatty acids using the radiometric growth inhibition assay.
Effects ofantioxidants, catalase, andSOD onfatty acid effects. In an 18-well microdilution plate (Linbro), 500 Ml PRBC were incubated with equal volumes of (a) butylated hydroxytoluene (BHT) (60 MM in 0.5% ethanol; Sigma Chemical Co.), (b) DL-a-tocopherol (vitamin E; 40 MuM in 0.5% ethanol; Sigma Chemical Co.), (c) SOD from bovine RBC (1 mg/ml; Sigma Chemical Co.), (d) catalase from bovine liver (1 mg/ml; Sigma Chemical Co.), (e) 0.5% ethanol (diluent of BHT and vitamin E), and (f) malaria medium, then incubated for 18 h in a candle jar at 37°C (16) . After incubation, blood smears were prepared and stained and parasitemias were determined. The parasite culture contents were centrifuged; the supernatant was replaced with an equal volume of malaria medium or with medium containing antioxidants, catalase, and SOD; and the PRBC pellet was resuspended. PRBC were dispensed into 96-well microdilution plates and were reacted with the fatty acids C22:6,n3 and C204,O-6for 2 h. Parasite growth inhibition was studied using the radiometric assay.
Comparison of use ofalbumin and DPPC micelles to incorporate fatty acids. Mixed fatty acid-DPPC micelles were compared with fatty acids (40 Mg/ml) sonicated in the presence of 3 mg/ml fatty acid-free albumin (Sigma Chemical Co.) for anti-P. fakiparum activity by using the radiometric assay.
Effects ofthefatty acid C22.6,4,3 on P. berghei. Virulent P. bergheiinfected blood stored under liquid N2 was used to infect one mouse by intraperitoneal inoculation, 7 d before the experiment. 2 d before the experiment, -300 Ml of blood was taken from the retroorbital plexus of the infected mouse and RBC level was adjusted to 107/ml in saline.
The mice used in experiments were injected with -5 X 106 RBC/ mouse i.p.
On the day ofthe experiment, the mice were randomly divided into groups offive, and initial parasitemia was determined in blood smears.
Fatty acid C22:6,n3 DPPC micelles were prepared (as described above) just before administration. Three experiments were conducted. In each, group 1 received, as a 400-Ml i.p. of (10 Ag), C22:6,.n3; group 2, 40 Mug ofDPPC; and group 3, saline. All groups were injected three times/d (9:30 a.m., 12:30 p.m., and 3:30 p.m.) for 4 d. Blood smears were prepared at 9:00 a.m. and 12:00 noon daily. On the 5th d the mice were bled for hematocrit determination.
Comparison of C22.f6,,-3 with C20..n 6 and C22.0fatty acids. The above fatty acids were freshly prepared in DPPC as described above and mice were treated with 10 Mg/400 Ml i.p., three times/d for 4 d. Blood smears were prepared and parasitemia determined.
Determination ofparasitemia. Giemsa-stained thin blood smears were examined under X 1,000 magnification and PRBC were counted in2 1O different areas of the smear. A minimum of 1,000 (very heavy infections) to 10,000 (low to moderate infections) RBC were studied/ mouse at a time, and %PRBC was expressed as parasitemia.
Statistical analysis. The results were compared by the paired twotailed Student's t test.
Results
Effects ofpolyunsaturatedfatty acids on P. falciparum in vitro. FATTY ACID CONCENTRATION (pg/ml) eration and death (Fig. 3 ). We found that immature and mature schizonts were more susceptible to the fatty acid-induced effects than were ring forms. However, the majority of ring forms were also found to be degenerated. The dead parasites were removed from the parasitophorous vacuole through its orifice to the exterior ofthe RBC. The fatty acid C22:6,n-3 caused > 90% death of P. falciparum. The survived parasites were in the ring form. C204n-6 caused 80% death or degeneration of the parasite. In addition to rings, a small percentage of schizonts also survived when treated with C20-4,6 In contrast, C22.0treated P. falciparum cultures were very similar to the parasite grown in the absence of fatty acids.
Effects offish oil. Fish oil compared with 40 Ag/ml C22:6,n-3 showed a much lower inhibition of the parasite growth. When PRBC were treated with 40 ,ug/ml offish oil for 2 h, the parasite inhibition was 20.5±8.5%. However, when the interaction time was increased to 20 h, more parasite inhibition (41.0±5.5%) was observed.
Effects ofoxidizedfatty acids. The oxidized forms of these fatty acids showed increased activity against P.falciparum (Fig.   4 ). Oxidized C22:6,n-3 and C20:4,n-6 showed significantly more antiparasitic activity (P < 0.01) than the nonoxidized forms ( Fig.  4 ). Antiparasitic effects were reduced by -50% if PRBC had been preincubated with BHT or vitamin E overnight, washed, and then exposed to the native fatty acids. Antiparasitic activity was reduced by > 70% when the preincubated PRBC were reacted with fatty acids in the presence of BHT and vitamin E (Fig. 4) . The effects of polyunsaturated fatty acids were also greatly reduced if the PRBC were treated with SOD or catalase ( Fig. 4 ). Ethanol (0.5%), the diluent for some of these reducing reagents, had no effect on parasite growth.
Effects ofpolyunsaturatedfatty acids on P. berghei infection in mice. Mice treated with the fatty acid vehicle DPPC showed parasitemias similar to those of mice that received saline (Fig.  5) . The parasitemia increased steadily in these mice. 6 d after infection, these mice showed a 60-fold increase in parasitemia (Fig. 5) . After a single injection of the fatty acid C22:6 ,n3, the parasitemia was significantly reduced from 1.65±0.40 to 0.25±0.04% (P < 0.001; Fig. 5 ). Throughout the course of the treatment, the parasitemia was maintained at a lower level than the initial parasitemia ( Fig. 5) . Compared with the mice that received DPPC or saline, the fatty acid-treated mice showed markedly lower parasitemia (P < 0.001). In the mice treated with DPPC or saline, the parasites grew rapidly, showing all different stages of the asexual and sexual stages. In contrast, in C22:6,n3-treated mice, 70-100% of the surviving parasites had "restricted growth" and appeared as a "dot" form. C2:4,n-6 was similarly effective in reducing the parasitemia, but C22:0 had no effect (data not presented).
Mice were examined for anemia. the monounsaturated fatty acid C18.1,9 more than tripled the parasiticidal effects of the molecules. At the concentrations tested, the fatty acids were not toxic for either normal RBC or PRBC and did not induce hemolysis (determined biochemically). Similar results were observed between the fatty acids solubilized in DPPC or albumin, indicat-ing that binding of fatty acids to albumin in vivo is unlikely to inhibit their antimalarial activity.
Results of the in vivo experiments confirmed the antiplasmodial effects of polyunsaturated fatty acids. The fatty acids C22:6,n-3 and C20:4,n-6 were capable of inhibiting the growth ofP. berghei in mice, but the saturated fatty acid C22:0 had no effect berghei. Importantly, the fatty acids showed no toxic effects in mice but, in fact, prevented the malaria-induced anemia.
Morphological studies confirmed the results obtained from the radiometric assay and revealed that fatty acids caused intraerythrocytic degeneration and death of P. falciparum. Intraerythrocytic degenerative forms (crisis forms) of malarial parasites were observed as early as 1944 by Taliaferro and Taliaferro (17) in P. brasilianum-infected cebus and spider monkeys. Since then, abnormal forms of intraerythrocytic Plasmodium species have been reported in rodents, primates, and hu- mans (for review see reference 11). Tumor necrosis factor a (TNFa; references 10, 18, 19) , or a combination of TNFa and interferon y with some undefined factors (5, 20) , has been suggested as candidates for crisis-inducing factors. Under in vitro conditions, we have found no evidence that any of the macrophage and lymphocyte cytokines; TNFa; lymphotoxin; interferon y; interleukins-1, -2, -4, or -8; or granulocyte macrophage colony-stimulating factor induce degeneration of intraerythrocytic P. falciparum in the presence or absence of complement and antimalarial antibody (12, 13, 21) . Others have suggested a role for molecules such as oxygen-derived reactive species (4, 22) , reactive nitrogen intermediates (23), oxidized polyamines (24) , and lipid peroxides (4, 7) . Our studies suggest that polyunsaturated fatty acids may constitute a crisis-inducing system in P. falciparum-infected RBC.
The mature mammalian RBC has negligible lipid metabolism, and Plasmodia cannot form fatty acids by de novo synthesis (25, 26) . Under the influence of the parasite, host RBC cell membrane is grossly altered in structure and composition. Radiolabeled studies have shown that the uptake of certain fatty acids increases dramatically after the infection with malaria parasites (27) (28) (29) (30) . Interestingly, malaria infection causes a marked reduction in the unsaturation index of RBC phospholipids, mainly as a result of the decreases in the amounts of C22:6,3, nC204n^a nd C182,n6 (27) . Our study shows that when PRBC are exposed to the same fatty acids or their methyl esters or oxidized fatty acids, parasiticidal effects occur, although the basis for the toxicity probably differs according to the state of the fatty acid. Our morphological studies showed that the fatty acids induced death of the parasite and that later these dead Antimalarial Properties ofPolyunsaturated Fatty Acids 965 A L f I I parasites move (via the parasitophorous vacuole orifice) to the exterior of the RBC. This observation suggests that the site of merozoite invasion, which acts as the orifice of the parasitophorous vacuole, has been damaged by the fatty acids or their derivatives.
It is evident from our studies that oxidized fatty acids are effective in inducing parasiticidal effects of P. falciparum. It is also likely that the effect ofthe parent nonoxidized fatty acid is related to fatty acid oxidation by the parasite or RBC, because antioxidants such as BHT and vitamin E markedly reduce the antimalarial activity ofthe fatty acids. Moreover, saturated and monounsaturated fatty acids, which are more resistant to oxidative attack, are much less effective than fatty acids with two or more double bonds. The nature of the oxidation products that induce the effect remains unclear. Lipid hydroperoxides (mainly mono-and dihydroxy derivatives) are major products of autooxidation, although a variety of other compounds (including alkanals, hydroxyalkanals, malonaldehyde, polymerized polar derivatives, and even volatile carbonyls) are produced (31) . Whether some or all of these products are effective at inducing degeneration of the parasite remains to be determined. The mechanism of action ofthe active agents is clearly dependent on their structure. Thus, fatty acid hydroperoxides may act by oxidizing reduced glutathione and thereby making the parasite more susceptible to oxidative stress, whereas malonaldehyde is thought to interfere with membrane function through its ability to form cross-linkages between proteins and lipids (4) . Recently it has been suggested that certain specific oxidized fatty acid products (e.g., oligomeric prostaglandins, which also inhibit the growth of P. falciparum [32] ) could act through their ability to bind calcium or inhibited phospholipase or protease activities (33) . Whether the oxidation products formed from the various polyunsaturated fatty acids used in our study act in a similar fashion remains to be established. Clearly, further studies with individual compounds are needed to clarify their action.
In vitro experiments ofthe present study showed that scavengers of reactive oxygen species and antioxidants reduced the fatty acid-induced killing of the parasite. It has been shown that administration ofbutylated dydroxyanisole, SOD, or catalase reduced cerebral pathology ofP. berghei ANKA mice (34) . Treatment of malaria-infected mice with these scavengers and antioxidants may counteract the fatty acid-mediated killing, if both treatments are given simultaneously. Treatment of mice with fatty acids alone, however, did not aggravate the pathology of malaria, probably related to the marked reduction of parasitemia.
Antimalarial activity of fish oil was relatively low. Fish oils are a source of triglycerides containing w-3 fatty acids, and the preparation used in this study contained 18% C20,5,n-3 and 12% C22:6,n-3 . It is possible that the remaining constituents ofthe fish oil counteracted the effects of C20.5,n-3 and C22:6,n-3. Alternatively, the triglycerides containing C2:5,n-3 and C22:6,n-3 may not be available to the parasite, because of the relatively larger size of the molecule.
The data presented in this paper provide new strategies that can be explored for the treatment of malaria at a time when new antimalarials are in demand. These fatty acids, in addition to being able to act directly on the parasites, may also activate neutrophils (35) and other effector cells for increased killing of malarial parasites.
